Greenberg Glusker
Cannabis Reclassification: Timeline and Impact
The United States Drug Enforcement Administration (“DEA”) has initiated the process to recategorize cannabis from a Schedule I drug to a Schedule III drug under the Controlled Substances Act (the “Act”).